1-7 of 7
Liu Xiaofan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Single-Center Study of Patients with Isolated Acquired Clotting Factors Deficiency: Clinical Features, Treatments and Prognosis

Yu Dandan, Wei Liu, Yunfei Chen, Rongfeng Fu, Liu Xiaofan, Ting Sun, Mankai Ju, Xinyue Dai, Feng Xue, Renchi Yang, Lei Zhang
Journal: Blood
Blood (2022) 140 (Supplement 1): 11325.
https://doi.org/10.1182/blood-2022-156991
Published: 2022
Journal Articles

Multi-Omics Analysis of Human Mesenchymal Stem Cell Guides Perinatal MSC Based Cellular Therapy for Splenectomy-Nonresponsive Refractory Immune Thrombocytopenia: A Phase I Clinical Trial

Yuchen Gao, Ying Chi, Yunfei Chen, Hui Yuan Li, Wentian Wang, Wenting Zheng, Ping Zhu, Jinying An, Yanan Duan, Ting Sun, Liu Xiaofan, Feng Xue, Wei Liu, Rongfeng Fu, Zhibo Han, Yingchi Zhang, Renchi Yang, Cheng Tao, Jun Wei, Xiaomin Zhang, Lei Zhang
Journal: Blood
Blood (2022) 140 (Supplement 1): 1974–1976.
https://doi.org/10.1182/blood-2022-156764
Published: 2022
Journal Articles

Switching from Eltrombopag to Hetrombopag in Patients with Primary Immune Thrombocytopenia (ITP): Post-Hoc Analysis of a Multicenter, Randomized Phase III Trial

Yu Hu, Renchi Yang, Ting Niu, Heng Mei, Liu Xiaofan, Yan Li, Hu Zhou, Ying Feng, Guangxun Gao, Peng Cheng, Ruibin Huang, Linhua Yang, Jianda Hu, Ming Hou, Yazhou Yao, Li Liu, Yi Wang, De-Pei Wu, Xuliang Shen, Jie Jin, Jianmin Luo, Zeng Yun, Xin Zhou, Ruixiang Xiang, Zhongxing Jiang, Yuansong Bai, Junye Xiong, Runzi Li, Jianjun Zou
Journal: Blood
Blood (2022) 140 (Supplement 1): 5543–5545.
https://doi.org/10.1182/blood-2022-162945
Published: 2022
Journal Articles

Factor X Activator for Hemophilia Patients with Inhibitors: A Phase 1, First-in-Human, Multi-Center, and Open-Label Trial

Wei Liu, Feng Xue, Rongfeng Fu, Bingjie Ding, Mengjuan Li, Ting Sun, Yunfei Chen, Liu Xiaofan, Mankai Ju, Xinyue Dai, Quanrui Wu, Zan Zhou, Xiaomin Wang, Jiaojiao Yu, Hu Zhou, Renchi Yang, Lei Zhang
Journal: Blood
Blood (2022) 140 (Supplement 1): 8474–8475.
https://doi.org/10.1182/blood-2022-159948
Published: 2022
Journal Articles

Eltrombopag Combining Rituximab Versus Eltrombopag for Treatment of Adult Immune Thrombocytopenia: A Single Center, Retrospective Cohort Study

Xu Yanmei, Liu Xiaofan, Yunfei Chen, Feng Xue, Wei Liu, Rongfeng Fu, Ting Sun, Mankai Ju, Renchi Yang, Lei Zhang
Journal: Blood
Blood (2022) 140 (Supplement 1): 5565–5566.
https://doi.org/10.1182/blood-2022-168463
Published: 2022
Journal Articles

Safety, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Adult Patients with Primary Immune Thrombocytopenia: A Randomized, Double-Blind and Placebo-Controlled Phase 1b Study

Renchi Yang, Hu Zhou, Yu Hu, Jie Yin, Junmin Li, Wenming Chen, Ruibin Huang, Yuping Gong, Chenwei Luo, Liu Xiaofan, Heng Mei, Bingjie Ding, Chengyuan Gu, Huiping Sun, Leng Yun, Dexiang Ji, Yan Li, Haiyan Shi, Hongyan Yin, Songhua Fan, Jian Wang, Weiguo Su
Journal: Blood
Blood (2021) 138 (Supplement 1): 16.
https://doi.org/10.1182/blood-2021-149895
Published: 2021
Journal Articles

Efficacy and Safety of Eltrombopag in Chinese Patients with Chronic Immune Thrombocytopenia: Stage 2 Results from a Multicenter Phase III Study

Renchi Yang, MD, Liu Xiaofan, MD, Junmin Li, MD, Ming Hou, MD PhD, Jin Jie, MD, Meijuan Huang, MD, Ziqiang Yu, PhD, Xiaojun Xu, MD PhD, Xiaohui Zhang
Journal: Blood
Blood (2018) 132 (Supplement 1): 3760.
https://doi.org/10.1182/blood-2018-99-110501
Published: 2018